Scholarlink

<p>Alveolar epithelial injury serves as a primary driver of idiopathic pulmonary fibrosis (IPF), where the functional integrity of alveolar type 2 (AT2) cells is essential for lung repair. Mitochondrial pyruvate carrier 2 (<i>Mpc2</i>) is a key component of the pyruvate transport system that sustains mitochondrial oxidative phosphorylation and energy metabolism in AT2 cells. However, the specific role of <i>Mpc2</i> in AT2 cell function and lung injury remains unclear.&#xa0;<i>Mpc2</i> expression in AT2 cells was examined in lung tissues from patients with IPF and in mice subjected to bleomycin-induced lung injury. AT2 cell–specific conditional knockout (CKO) mouse models, single-cell transcriptomic analyses, and AT2 organoid cultures were employed to investigate the functional consequences of <i>Mpc2</i> deficiency during lung injury.&#xa0;<i>Mpc2</i> expression in AT2 cells was significantly reduced in patients with IPF and in mice following bleomycin-induced lung injury. Conditional deletion of <i>Mpc2</i> in AT2 cells resulted in decreased expression of the Na⁺/K⁺-ATPase α1 subunit (ATP1A1) and surfactant protein C (SPC), impaired AT2 differentiation during lung injury, and a shift in pulmonary inflammatory profiles toward neutrophil predominance. These changes were associated with increased early mortality in male mice after bleomycin challenge. In contrast, female mice with AT2-specific <i>Mpc2</i> deletion did not exhibit a significant survival disadvantage but developed more severe pulmonary fibrosis and sustained impairment of AT2 cell differentiation at later stages following bleomycin administration.&#xa0;<i>Mpc2</i> is essential for maintaining AT2 cell function during lung injury and contributes to the regulation of alveolar epithelial differentiation and inflammatory balance. Targeting <i>Mpc2</i> may offer novel therapeutic opportunities for lung injury-related diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mitochondrial Pyruvate Metabolism Controls Alveolar Stem Cell Fate and Inflammatory Balance

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月3日

查看全文
  • Zuokuan He,
  • Xue Li,
  • Xuan Miao,
  • Guiying Xu,
  • Sisi Wang,
  • Li Li,
  • Qi Wu,
  • Huaiyong Chen

摘要

Alveolar epithelial injury serves as a primary driver of idiopathic pulmonary fibrosis (IPF), where the functional integrity of alveolar type 2 (AT2) cells is essential for lung repair. Mitochondrial pyruvate carrier 2 (Mpc2) is a key component of the pyruvate transport system that sustains mitochondrial oxidative phosphorylation and energy metabolism in AT2 cells. However, the specific role of Mpc2 in AT2 cell function and lung injury remains unclear. Mpc2 expression in AT2 cells was examined in lung tissues from patients with IPF and in mice subjected to bleomycin-induced lung injury. AT2 cell–specific conditional knockout (CKO) mouse models, single-cell transcriptomic analyses, and AT2 organoid cultures were employed to investigate the functional consequences of Mpc2 deficiency during lung injury. Mpc2 expression in AT2 cells was significantly reduced in patients with IPF and in mice following bleomycin-induced lung injury. Conditional deletion of Mpc2 in AT2 cells resulted in decreased expression of the Na⁺/K⁺-ATPase α1 subunit (ATP1A1) and surfactant protein C (SPC), impaired AT2 differentiation during lung injury, and a shift in pulmonary inflammatory profiles toward neutrophil predominance. These changes were associated with increased early mortality in male mice after bleomycin challenge. In contrast, female mice with AT2-specific Mpc2 deletion did not exhibit a significant survival disadvantage but developed more severe pulmonary fibrosis and sustained impairment of AT2 cell differentiation at later stages following bleomycin administration. Mpc2 is essential for maintaining AT2 cell function during lung injury and contributes to the regulation of alveolar epithelial differentiation and inflammatory balance. Targeting Mpc2 may offer novel therapeutic opportunities for lung injury-related diseases.